申请人:The Board of Regents of the University of Texas System
公开号:US11013704B2
公开(公告)日:2021-05-25
The present disclosure relates to methods of using a compound to induce regeneration of hematopoietic stem cells or increase the recovery of red blood cells. In some aspects, the present methods can be used to with or in place of erythropoietin in patients to mitigate the side effects of erythropoietin.
本公开涉及使用化合物诱导造血干细胞再生或增加红细胞恢复的方法。在某些方面,本方法可与促红细胞生成素一起或代替促红细胞生成素用于患者,以减轻促红细胞生成素的副作用。